High one year mortality in adults with sickle cell disease and end-stage renal disease

British Journal of Haematology

Volumn 159, Issue 3, 2012, Pages 360-367

  Mcclellan, Ann C ^a,b   Luthi, Jean Christophe ^c,d   Lynch, Janet R ^e   Soucie, J Michael ^a   Kulkarni, Roshni ^a,f   Guasch, Antonio ^c   Huff, Edwin D ^g   Gilbertson, David ^h   Mcclellan, William M ^c   Debaun, Michael R ⁱ  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Mid Atlantic Renal Coalition   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g Centers for Medicare and Medicaid Services   (United States)

^h USRDS   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

Author keywords

Disparities; End stage renal disease; Kidney disease; Mortality; Sickle cell disease

Indexed keywords

CREATININE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BODY MASS; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT DURATION; TREATMENT RESPONSE; CHRONIC KIDNEY FAILURE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANEMIA, SICKLE CELL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84867469590     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12024     Document Type: Article

References (13)

1. Bradbury, B.D., Fissell, R.B., Albert, J.M., Anthony, M.S., Critchlow, C.W., Pisoni, R.L., Port, F.K. & Gillespie, B.W. (2007) Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clinical Journal of American Society of Nephrology, 2, 89-99.
2. Collins, A.J., Foley, R.N., Herzog, C., Chavers, B., Gilbertson, D., Ishani, A., Kasiske, B., Liu, J., Mau, L.W., McBean, M., Murray, A., St Peter, W., Guo, H., Li, Q., Li, S., Peng, Y., Qiu, Y., Roberts, T., Skeans, M., Snyder, J., Solid, C., Wang, C., Weinhandl, E., Zaun, D., Arko, C., Chen, S.C., Dalleska, F., Daniels, F., Dunning, S., Ebben, J., Frazier, E., Hanzlik, C., Johnson, R., Sheets, D., Wang, X., Forrest, B., Constantini, E., Everson, S., Eggers, P. & Agodoa, L. (2009) United States Renal Data System 2008 Annual Data Report. American Journal of Kidney Diseases, 53, S1-S374.
3. Hassell, K.L. (2010) Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine, 38, S512-S521.
4. McClellan, W.M., Wasse, H., McClellan, A.C., Kipp, A., Waller, L.A. & Rocco, M.V. (2009) Treatment center and geographic variability in pre-ESRD care associate with increased mortality. Journal of the American Society of Nephrology, 20, 1078-1085.
5. National Kidney Foundation (2001a) III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. American Journal of Kidney Diseases, 37, S137-181.
6. National Kidney Foundation (2001b) IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. American Journal of Kidney Diseases, 37, S182-238.
7. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases, 39, S1-266.
8. Pastan, S., Soucie, J.M. & McClellan, W.M. (2002) Vascular access and increased risk of death among hemodialysis patients. Kidney International, 62, 620-626.
9. Piepsz, A., Tondeur, M. & Ham, H. (2006) Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. European Journal of Nuclear Medicine and Molecular Training, 33, 1477-1482.
10. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
11. Powars, D.R., Elliott-Mills, D.D., Chan, L., Niland, J., Hiti, A.L., Opas, L.M. & Johnson, C. (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Annals of Internal Medicine, 115, 614-620.
12. Quinn, C.T., Rogers, Z.R., McCavit, T.L. & Buchanan, G.R. (2010) Improved survival of children and adolescents with sickle cell disease. Blood, 115, 3447-3452.
13. Ware, R.E., Rees, R.C., Sarnaik, S.A., Iyer, R.V., Alvarez, O.A., Casella, J.F., Shulkin, B.L., Shalaby-Rana, E., Strife, C.F., Miller, J.H., Lane, P.A., Wang, W.C. & Miller, S.T. (2010) Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. Journal of Pediatrics, 156, 66-70 e1.